Tadalafil
- Product NDC
- 71335-1587
- 11-digit product format
- 713351587
- Labeler code
- 71335
- Product ID
- 71335-1587_3b6bc9dc-1670-4e55-8cf6-7221589070ef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209167
- Marketing category
- ANDA
- Marketing start
- 2019-03-27
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tadalafil
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TADALAFIL | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 742SXX0ICT |
| Rxcui | 402019 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-1587-1 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-2 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-3 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-4 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-5 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-6 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-7 | 2024-05-21 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
| 71335-1587-7 | 2024-01-30 | C162847 | 48780-1 | 1030e365-64d0-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use TADALAFIL TABLETS safely and effectively. See full prescribing information for TADALAFIL TABLETS. TADALAFIL tablets, for oral use Initial U.S. Approval: 2003 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-1587-1 | Tadalafil | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 8 |
| 71335-1587-2 | Tadalafil | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | | 8 |
| 71335-1587-3 | Tadalafil | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 8 |
| 71335-1587-4 | Tadalafil | 5 in 1 BOTTLE | TABLET, FILM COATED | 5 | | 8 |
| 71335-1587-5 | Tadalafil | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 8 |
| 71335-1587-6 | Tadalafil | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | | 8 |
| 71335-1587-7 | Tadalafil | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | | 8 |
| 71335-1587-8 | Tadalafil | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1587 | TADALAFIL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 8 package rows | 20241120_aa8d165b-0c7d-497a-b56a-7c62ebc0a5d2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1587-1 | 71335158701 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-1587-1) | 2020-04-30 | 0000-00-00 | No | No | Current |
| 71335-1587-2 | 71335158702 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-1587-2) | 2020-06-16 | 0000-00-00 | No | No | Current |
| 71335-1587-3 | 71335158703 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-1587-3) | 2020-07-22 | 0000-00-00 | No | No | Current |
| 71335-1587-4 | 71335158704 | 5 TABLET, FILM COATED in 1 BOTTLE (71335-1587-4) | 2020-09-11 | 0000-00-00 | No | No | Current |
| 71335-1587-5 | 71335158705 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-1587-5) | 2020-08-14 | 0000-00-00 | No | No | Current |
| 71335-1587-6 | 71335158706 | 20 TABLET, FILM COATED in 1 BOTTLE (71335-1587-6) | 2024-10-31 | 0000-00-00 | No | No | Current |
| 71335-1587-7 | 71335158707 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-1587-7) | 2020-06-23 | 0000-00-00 | No | No | Current |
| 71335-1587-8 | 71335158708 | 100 TABLET, FILM COATED in 1 BOTTLE (71335-1587-8) | 2020-06-23 | | No | No | Current |